16:03 EST Maravai Lifesciences (MRVI) jumps 6% to $5.85 after MAI IP acquisition announcement
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVI:
- Maravai LifeSciences Restructures Leadership Amid Revenue Update
- Maravai sees 2024 revenue at midpoint of $255M-$265M range
- Maravai Lifesciences initiated with a Neutral at Guggenheim
- Maravai Lifesciences chairman Carl Hull to retire, R. Andrew Eckert to succeed
- Maravai LifeSciences Appoints New Chairman Amid Leadership Transition